HARP Diagnostics is developing the world’s first automated, user-friendly and rapid, stool testing platform for home monitoring of gastrointestinal conditions, like Inflammatory Bowel Diseases - IBD (Crohn’s and Colitis).
The platform offers an end-to-end solution, from seamless & user-friendly sample collection (with no direct contact with the stool sample) to rapid and accurate results, with built-in safeguards to eliminate human error.
The patented portable device can be used by patients from the comfort of their home, or by healthcare providers at the doctors office (point-of-care) - with no mess, no user error. It is designed to be user-friendly and fail-safe even for people with no training, ensuring more patients test themselves regularly and easily.
Test data is shared with the doctor through a cloud-connected system, helping to make better, real-time data-driven decisions about treatment adjustments of the chronic patients, dramatically improving continuity of care and long-term outcomes, while reducing healthcare related costs.
HARP is the winner of the 2025 IBD Shark Tank Competition of the American Chron’s and Colitis Foundation.